EAGLE PHARMACEUTICALS, INC. Annual Interest Expense in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2012 to 2022.
  • Eagle Pharmaceuticals, Inc. Interest Expense for the quarter ending June 30, 2023 was $1.45M, a 162% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. Interest Expense for the twelve months ending June 30, 2023 was $6.09M, a 256% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Interest Expense for 2022 was $4.05M, a 147% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Interest Expense for 2021 was $1.64M, a 36.6% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Interest Expense for 2020 was $2.58M, a 4.06% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $4.05M +$2.41M +147% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 $1.64M -$942K -36.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $2.58M -$109K -4.06% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $2.69M -$50K -1.83% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $2.74M +$1.6M +141% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-05
2017 $1.14M +$1.13M +14100% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $8K -$3K -27.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $11K +$3K +37.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 $8K -$301K -97.4% Oct 1, 2013 Sep 30, 2014 10-K 2017-03-15
2013 $309K +$218K +240% Oct 1, 2012 Sep 30, 2013 10-K 2016-02-29
2012 $91K Oct 1, 2011 Sep 30, 2012 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.